Home

Blog

How People Voted

31% For, 69% Against

Take Action

Alert Your Friends and Colleagues
Write Your Representative in Congress
Save & Share
del.icio.us
Digg
Facebook
Google
Reddit
Yahoo!

H.R. 6568, The Tom Lantos Pulmonary Hypertension Research and Education Act of 2008

  • This item is from the 110th Congress (2007-2008) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.

Comparing revision saved on September 27, 2008, 07:32:53 (webmaster), with revision saved on October 3, 2008, 19:32:27 (webmaster):

H.R. 6568 would direct the Secretary of Health and Human Services to encourage research and carry out an educational campaign with respect to pulmonary hypertension.

== Detailed Summary ==

<summary>
(LogTom Lantos Pulmonary Hypertension Research and Education Act of 2008 - Expresses the sense of the Congress that: (1) the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH) and the Director of the National Heart, Lung, and Blood Institute, should continue aggressive work on pulmonary hypertension; and (2) the Director of the Institute should continue research to expand the understanding of the causes of, and to find a cure for, pulmonary hypertension.

Requires inclusion of information on the status of pulmonary hypertension research at NIH
in biennial reports to editCongress.

Requires
the wikiSecretary, acting through the Director of the Centers for Disease Control and bePrevention (CDC), to carry out an educational campaign to increase public awareness of pulmonary hypertension.

Requires
the firstSecretary, acting through the Administrator of the Health Resources and Services Administration (HRSA) and the Director of CDC, to provide a detailed summarycarry out an educational campaign to increase awareness of pulmonary hypertension among health care providers.

Directs
the bill!)Comptroller General to study and report to Congress on Medicare and Medicaid coverage standards that apply to patients with pulmonary hypertension, including standards for all therapies approved by the Food and Drug Administration (FDA) for the treatment of pulmonary hypertension.
</summary>

<!--Leave in the 'summary' tags if you want the latest summary from the Congressional Research Service automatically to replace the text between the tags once it becomes available. -->

== Status of the Legislation ==

<status>
Latest Major Action: 9/26/2008: Received in the Senate.
</status>

<!-- Leave in the 'status' tags if you want the latest reported status from THOMAS automatically to replace the text between the tags once it becomes available. -->

== Points in Favor ==

(Log in to edit the wiki and be the first to show why the bill should pass!)
<!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! -->

== Points Against ==

(Log in to edit the wiki and be the first to show why the bill should not pass!)
<!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! -->

« Return to Revision History.


Cost per :

From the Blog

Silly Season on Capitol Hill

Congress has all the planning skills and foresight of a teenager. Y’know how when mom and dad are coming back from their weekend away, the kid tries to do all the chores for the weekend in the last hour? That’s Congress. So as we wrap up ...

Visitor Comments Comments Feed for This Bill

There are currently no comments for this bill.

RSS Feeds for This Bill

Keep yourself updated on user contributions and debates about this bill! (Learn more about RSS.)